Analysts Set DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Target Price at $29.50

DENTSPLY SIRONA Inc. (NASDAQ:XRAY) has earned an average rating of “Hold” from the nine ratings firms that are presently covering the firm, MarketBeat Ratings reports. Six analysts have rated the stock with a hold recommendation and three have issued a buy recommendation on the company. The average 1-year price target among analysts that have updated their coverage on the stock in the last year is $29.50.

Several brokerages have issued reports on XRAY. Robert W. Baird dropped their price target on DENTSPLY SIRONA from $31.00 to $24.00 and set a “neutral” rating for the company in a research note on Friday, November 8th. Leerink Partners cut shares of DENTSPLY SIRONA from an “outperform” rating to a “market perform” rating in a research report on Thursday, November 7th. Leerink Partnrs downgraded DENTSPLY SIRONA from a “strong-buy” rating to a “hold” rating in a report on Thursday, November 7th. Needham & Company LLC cut their price objective on DENTSPLY SIRONA from $34.00 to $29.00 and set a “buy” rating on the stock in a research report on Friday, October 25th. Finally, Barrington Research dropped their target price on shares of DENTSPLY SIRONA from $36.00 to $24.00 and set an “outperform” rating on the stock in a report on Friday, November 8th.

Institutional Trading of DENTSPLY SIRONA

Large investors have recently made changes to their positions in the stock. Raymond James Trust N.A. raised its stake in DENTSPLY SIRONA by 4.9% during the 2nd quarter. Raymond James Trust N.A. now owns 9,658 shares of the medical instruments supplier’s stock valued at $241,000 after buying an additional 453 shares during the last quarter. State of Alaska Department of Revenue grew its holdings in shares of DENTSPLY SIRONA by 2.4% in the third quarter. State of Alaska Department of Revenue now owns 23,545 shares of the medical instruments supplier’s stock worth $637,000 after acquiring an additional 560 shares during the period. LRI Investments LLC increased its position in DENTSPLY SIRONA by 82.7% during the second quarter. LRI Investments LLC now owns 1,246 shares of the medical instruments supplier’s stock valued at $31,000 after acquiring an additional 564 shares during the last quarter. Diversified Trust Co lifted its holdings in DENTSPLY SIRONA by 3.0% in the second quarter. Diversified Trust Co now owns 19,637 shares of the medical instruments supplier’s stock valued at $489,000 after acquiring an additional 566 shares during the period. Finally, MML Investors Services LLC grew its stake in shares of DENTSPLY SIRONA by 2.1% during the 3rd quarter. MML Investors Services LLC now owns 29,682 shares of the medical instruments supplier’s stock valued at $803,000 after purchasing an additional 620 shares during the period. 95.70% of the stock is currently owned by institutional investors.

DENTSPLY SIRONA Trading Up 4.0 %

NASDAQ:XRAY opened at $19.52 on Thursday. DENTSPLY SIRONA has a 1 year low of $17.21 and a 1 year high of $37.60. The stock’s fifty day moving average price is $23.25 and its two-hundred day moving average price is $25.05. The company has a debt-to-equity ratio of 0.72, a current ratio of 1.25 and a quick ratio of 0.84. The company has a market cap of $3.88 billion, a P/E ratio of -9.44, a P/E/G ratio of 1.84 and a beta of 1.02.

DENTSPLY SIRONA (NASDAQ:XRAY) last released its quarterly earnings results on Thursday, November 7th. The medical instruments supplier reported $0.50 EPS for the quarter, beating analysts’ consensus estimates of $0.48 by $0.02. The firm had revenue of $951.00 million during the quarter, compared to analyst estimates of $939.10 million. DENTSPLY SIRONA had a negative net margin of 10.59% and a positive return on equity of 12.62%. The business’s revenue for the quarter was up .4% on a year-over-year basis. During the same period in the previous year, the business earned $0.49 EPS. As a group, analysts expect that DENTSPLY SIRONA will post 1.84 EPS for the current year.

About DENTSPLY SIRONA

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.